Merck Co., Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

17:10 EDT 17 Oct 2018 | BioPortfolio Reports

Merck Co., Inc. Strategy, SWOT and Corporate Finance Report


Merck Co., Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Merck Co., Inc. Merck Co. or the company', known as Merck Sharp Dohme MSD outside the US and Canada, is a healthcare company. The company delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company sells prescription medicine and pharmaceutical products for the treatment of cardiovascular, cancer, immune disorders, infectious, respiratory and women's diseases, and diabetes. It commercializes products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It also sells Vaccine products that include preventive pediatric, adolescent and adult vaccines to physicians, wholesalers, physician distributors and government entities. Apart from this, Merck Co. manufactures and markets animal health products, including vaccines and sells to veterinarians, distributors and animal producers. The company has operations across the world. Merck Co. is headquartered in Kenilworth, New Jersey, the US.


Detailed information on Merck Co., Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Merck Co., Inc. in the form of a SWOT analysis

An indepth view of the business model of Merck Co., Inc. including a breakdown and examination of key business segments

Intelligence on Merck Co., Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Merck Co., Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Merck Co., Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Merck Co., Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Merck Co., Inc.'s business structure, strategy and prospects.

Original Article: Merck Co., Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175


More From BioPortfolio on "Merck Co., Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Quick Search


Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...